Application of B-type diuretic peptide in prognosis analysis of acute pulmonary embolism

Recently, researchers from respiratory department of Affiliated Hospital of Qinghai University published papers to study the value and application of plasma B-type diuretic peptide (BNP) in the prognosis evaluation of acute pulmonary embolism (APE) It is pointed out that BNP concentration in plasma can be used as an index for risk stratification and prognosis evaluation of ape to guide clinical diagnosis and treatment This article was published in the 22nd issue of Jilin medicine in 2014   120 patients with ape were diagnosed by spiral CT and pulmonary arteriography (CTPA), and the BNP level in plasma was measured within 6 hours Then the correlation between BNP level and the incidence of massive embolism, mortality, pulmonary hypertension and other clinical risk symptoms was analyzed   There were 56 cases with BNP > 150 ng / L and 64 cases with BNP < 150 ng / L The incidence of right ventricular dysfunction, pulmonary hypertension and right ventricular overload in ape patients with elevated BNP was significantly higher than that in ape patients with normal BNP The incidence of syncope, cardiogenic shock and mortality in ape patients with BNP increased were significantly higher than those in ape patients with BNP normal   Related links: http://med.wanfangdata.com.cn/periodic/jlyx-hlb